XERS
Xeris Pharmaceuticals Inc
8.20$
+4.9%
vs. previous close
Closing price · As of: Sep 17, 2026
Investor relations
Report Dates
Investor relations overview for Xeris Pharmaceuticals Inc (XERS): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/05/2026.
Next report
11/05/2026
Last report
08/06/2026
EPS estimate beaten
Full history
13 of 39 quarters (33%)
Last 16 quarters
7 of 16 quarters (44%)
Earnings Call Transcripts
- 08/06/2026 Earnings Call Q2 2026 Open →
- 05/07/2026 Earnings Call Q1 2026 Open →
- 03/02/2026 Earnings Call Q4 2025 Open →
- 11/06/2025 Earnings Call Q3 2025 Open →
- 08/07/2025 Earnings Call Q2 2025 Open →
- 05/08/2025 Earnings Call Q1 2025 Open →
- 03/06/2025 Earnings Call Q4 2024 Open →
- 11/08/2024 Earnings Call Q3 2024 Open →
- 08/08/2024 Earnings Call Q2 2024 Open →
- 05/09/2024 Earnings Call Q1 2024 Open →
News on This Stock
- 09/09/2026 Xeris Biopharma Holdings, Inc. (XERS): Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗
- 08/06/2026 Xeris Biopharma Holdings, Inc. (XERS): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
- 07/17/2026 Xeris Biopharma Holdings, Inc. (XERS): Unregistered Sales of Equity Securities; Other Events · sec.gov Open ↗
Automatically matched wire and portal stories; external links open the original source.
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.